Active Shortage Injection Other
Hydroxocobalamin Injection · 676 days since initial FDA posting
Brand: HYDROXOCOBALAMIN
FDA lists Hydroxocobalamin Injection as Active Shortage (Teva Pharmaceuticals USA, Inc.).
Availability on file: Unavailable
Hydroxocobalamin Injection: Active Shortage
Unavailable Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Hydroxocobalamin Injection
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Dosage Form
- Injection
- Presentation
- Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30)
- Package NDC
- 0591-2888-30
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Nov 4, 2024
- Last Updated
- Mar 16, 2026
- Therapeutic Category
- Other
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Supply is currently anticipated in June 2026
Nearby, Other Hydroxocobalamin Shortage Records
FDA reason on file: Supply is currently anticipated in June 2026. General shortage guidance lives on the tracker hub.